U.S. CDC Advisory Committee Unanimously Recommends Johnson & Johnson COVID-19 Vaccine as a Booster for All Eligible Individuals Who Receive Authorized COVID-19 Vaccines

NEW BRUNSWICK, N.J., October 21, 2021 – Johnson &Johnson (the Company) today announced that the U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP), has recommended its COVID-19 vaccine as a booster for all eligible individuals who receive an authorized COVID-19 vaccine. “Today’s recommendation supports the use of the Johnson &Johnson COVID-19 vaccine as a booster for eligible individuals in the U.S. regardless of which vaccine they initially receive,” said Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer at Johnson &Johnson. “The Johnson &Johnson vaccine provided 94 percent protection in the U.S. against COVID-19 when given as a booster following the single-shot Johnson &Johnson vaccine, and due to its unique mechanism of action, offers long-lasting, durable protection. We remain confident in the benefit it will provide to millions around the world.” The Johnson &Johnson COVID-19 vaccine was recommended as a booster for adults aged 18 and older who received the Johnson &Johnson single-shot vaccine at least two months earlier. A booster dose of the Johnson &Johnson COVID-19 vaccine was also recommended for eligible adults at least six months following the second dose of an authorized mRNA vaccine.The ACIP recommendation has been forwarded to the Director of the CDC and the U.S. Department of Health and Human Servic...
Source: Johnson and Johnson - Category: Pharmaceuticals Source Type: news

Related Links:

This report describes how the authors adapted the research methodologies to continue work throughout the pandemic, despite various restrictions. The original studies had very high participation rates because of several methodological approaches that minimized barriers, especially in-person data collection. During the pandemic, distancing requirements precluded replication of these same methods. Research strategies that enabled staff participation during working hours, with designated time allotted for participation, was key for ensuring high participation rates, as access to technology, availability of free time and oth...
Source: Housing, Care and Support - Category: International Medicine & Public Health Authors: Source Type: research
I’m in the northeast, and it’s becoming a pain in the a** to eat anywhere. Everywhere is full, have to book a reservation way ahead to get anything. Many restaraunts have started to hold a credit card on file for reservation and charge fees for cancelation, seems to have made it better. Is this how it was pretty pandemic, I can’t remember? Is it this annoying other parts of the country? I will also add, I only sit down at a restaraunt with my spouse maybe once or twice a month.
Source: Student Doctor Network - Category: Universities & Medical Training Authors: Tags: Pain Medicine Source Type: forums
for Medicare advantage plan - EviCore require Orthopedic surgeon available at site for Vertebral Augmentation. Have any one come a cross that kind of situation ? What you do ?
Source: Student Doctor Network - Category: Universities & Medical Training Authors: Tags: Pain Medicine Source Type: forums
New York has announced three more cases of the omicron variant of the coronavirus, bringing to eight the number of state cases linked to the new variant
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news
If we keep allowing this virus to spread through unvaccinated populations, the next variant could be even more deadlyCoronavirus – latest updatesSee all our coronavirus coverageIt ’s almost two years since we first heard of Covid-19, and a year since the first Covid vaccines were rolled out. Yet this staggering progress is being squandered. We have drifted for months now, with richer countries, taking a very blinkered domestic focus, lulled into thinking that the worst of t he pandemic was behind us. This variant reminds us all that we remain closer to the start of the pandemic than the end.There is a lot we ne...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus Infectious diseases Vaccines and immunisation Health Epidemics Science Society World Health Organization Source Type: news
Sir Jeremy Farrar, director of Wellcome Trust, suggests emergence of Omicron variant means pandemic is far from overCoronavirus – latest updatesSee all our coronavirus coverageThe emergence of the Omicron variant shows that the world is “closer to the start of the pandemic than the end”, one of Britain’s most senior scientific figures has warned, as he lamented a lack of political leadership over Covid.Sir Jeremy Farrar, the director of the Wellcome Trust whostepped down as a government scientific adviser last month, said the progress in combatting Covid-19 since its emergence was “being squan...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus Vaccines and immunisation Infectious diseases Science World news UK news Medical research Health Source Type: news
Source: Health Care Renewal - Category: Health Management Tags: core values Source Type: blogs
Twitter has added a warning to anyone clicking on the link to this abstract.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: Healthcare /healthcare Innovation /innovation Social Media /social-media business pharma Source Type: news
Christmas parties Johnson’s staff held last year broke coronavirus restrictions.
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news
NEW BRUNSWICK, N.J., October 20, 2021 – Johnson &Johnson (NYSE: JNJ) (the Company) today announced the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for a booster dose of the Johnson &Johnson COVID-19 vaccine for adults aged 18 and older at least two months following primary vaccination with single-shot Johnson &Johnson COVID-19 vaccine; and for eligible individuals who received a different authorized or approved COVID-19 vaccine. The Johnson &Johnson booster shot will be the same formulation and dosage as the primary shot. The EUA follows a unanimous recommendat...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Latest News Source Type: news
More News: Allergy | Allergy & Immunology | Biotechnology | Bleeding | Brain | Cancer & Oncology | Cardiology | Cardiovascular | Centers for Disease Control and Prevention (CDC) | Clinical Trials | Coronavirus | COVID-19 | Department of Health | Emergency Medicine | Environmental Health | Eyes | Guillain-Barr Syndrome | Headache | Health Management | Heart | Hospitals | Hypertension | Infectious Diseases | Learning | Legislation | Men | Migraine | Neurology | Neuroscience | Pain | Pandemics | Pharmaceuticals | Pregnancy | Pulmonary Hypertension | Respiratory Medicine | SARS | Science | Skin | Tinnitus | Universities & Medical Training | Vaccines